Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
Trial evaluating tissue oximetry measurements during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. The study is curr…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating tazemetostat for recurrent ovarian or endometrial cancers; the study is currently not recruiting…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
A completed multicancer registry study (PREFER) assessing the prevalence of actionable biomarkers and driver mutations across advanced cance…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance [Phase 2]
A Phase 2 trial from Korea University Guro Hospital is evaluating secondary cytoreductive surgery for relapsed ovarian cancer in patients wh…
-
CLINICAL_TRIALS withdrawal · 2025-03-05Clinical Trial Update: PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial of PEP-DC and OC-DC vaccines for ovarian cancer has been withdrawn. The trial was listed as Withdrawn in Clinical…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2, Phase 3]
This clinical trial update reports results from a Phase 2/3 study evaluating pegylated liposomal doxorubicin in combination with atezolizuma…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Proteogenomic Signatures Analysis In Ovarian Cancer [NA]
A clinical trial update focusing on proteogenomic signatures analysis in ovarian cancer, with the study listed as active but not currently r…
-
CLINICAL_TRIALS other · 2025-03-04Clinical Trial Update: Patients Derived Organoids in Ovarian Cancer [NA]
A clinical trial (NCT06085404) sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS is recruiting participants. It studi…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
This is a completed clinical trial update examining regional distribution of lymph node metastasis in epithelial ovarian cancer; results are…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Study of AK112 in the Treatment of Advanced Gynecological Tumors [Phase 2]
Phase 2 study of AK112 for advanced gynecologic tumors has been completed, evaluating efficacy in ovarian, cervical, and endometrial cancers…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients
Clinical trial update on ChemoINTEL assay development that correlates in-vitro cytotoxic drug-induced apoptosis with patient response to che…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Northwestern University is conducting a specimen and data study for ovarian cancer early detection and prevention. The trial is currently re…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Ovarian Cancer Identification on CT Using Deep Learning
A clinical trial evaluating deep learning methods to identify ovarian cancer on CT scans; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer [Phase 1]
A Phase 1 clinical trial of SCT-001 CAR T Cells Therapy for relapsed and refractory ovarian cancer and related peritoneal cancers is not yet…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST [Phase 1]
Phase 1 trial of APG-2449 as monotherapy or with pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer and ad…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
This entry describes an ongoing clinical trial evaluating an MSLN-targeted PET imaging tracer for malignant tumors, with recruitment underwa…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients [Phase 2]
A Phase 2 trial evaluating Fluzoparib in combination with Apatinib versus Fluzoparib alone in relapsed ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours [Phase 1]
Phase 1 first-in-human study to evaluate safety, tolerability and antineoplastic activity of OATD-02 in patients with selected advanced/meta…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer [Phase 1]
Phase 1 study evaluating intraperitoneal carboplatin with intravenous paclitaxel and bevacizumab in untreated ovarian cancer has completed.
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Genetic Testing in African Americans [NA]
Clinical trial update on genetic testing in African American participants related to ovarian cancer, endometrial cancer, and peritoneal canc…
-
CLINICAL_TRIALS withdrawal · 2025-02-21Clinical Trial Update: QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy [Phase 1, Phase 2]
The QUILT-3.051 trial evaluating the NANT Ovarian Cancer Vaccine in epithelial ovarian cancer has been withdrawn in subjects who progressed …
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients [EARLY_Phase 1]
Early-phase 1 clinical trial evaluating heated intraperitoneal chemotherapy with doxorubicin and cisplatin for pediatric abdominal/pelvic tu…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario
An ongoing real-world clinical study is examining outcomes in advanced ovarian cancer patients based on homologous recombination status and …
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: MiniLap Vs Standard Laparoscopy in Prophylactic Bilateral Salpingo-oophorectomy in BRCA-Mutated Patients [NA]
Clinical trial comparing MiniLap versus standard laparoscopy for prophylactic bilateral salpingo-oophorectomy in BRCA mutation carriers; rec…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine [Phase 1]
First-in-human Phase 1 study of OVM-200, a therapeutic cancer vaccine, being tested in prostate cancer, non-small cell lung cancer, and ovar…